Cross-source evidence timeline

Retatrutide research timeline

Follow 27 selected, directly cited source records from July 20, 2024 through November 13, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

27Selected records
3Source years
3Evidence lanes
November 13, 2026Latest source date

Source year

2026

22 records
  1. Clinical trials

    ClinicalTrials.gov record NCT06297603↗

    PeptideScanner retained ClinicalTrials.gov record NCT06297603 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was retatrutide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT07232719↗

    PeptideScanner retained ClinicalTrials.gov record NCT07232719 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was retatrutide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT05936151↗

    PeptideScanner retained ClinicalTrials.gov record NCT05936151 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was retatrutide.↗

  4. Literature metadata

    Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain.↗

    PubMed lists PMID 42853576 in JAMA as Journal Article, with publication-date metadata of 2026-11-03 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Retatrutide in adults with obesity and type 2 diabetes: what have we learned from TRIUMPH-2?↗

    PubMed lists PMID 42849462 in Lancet (London, England) as Journal Article, with publication-date metadata of 2026-10-10 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT07035093↗

    PeptideScanner retained ClinicalTrials.gov record NCT07035093 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-25, and PeptideScanner's reviewed identity mapping was retatrutide.↗

  7. Clinical trials

    ClinicalTrials.gov record NCT06383390↗

    PeptideScanner retained ClinicalTrials.gov record NCT06383390 at 2026-09-09T19:17:17.103Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was retatrutide.↗

  8. Clinical trials

    ClinicalTrials.gov record NCT05929066↗

    PeptideScanner retained ClinicalTrials.gov record NCT05929066 at 2026-09-09T19:17:17.407Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was retatrutide.↗

  9. Literature metadata

    PubMed record PMID 42567543↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42567543 at 2026-08-10T10:49:13.603Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-08-07. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.↗

  10. Literature metadata

    PubMed record PMID 38323122↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 38323122 at 2026-08-10T10:49:06.879Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2024-02-07. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.↗

  11. Clinical trials

    ClinicalTrials.gov record NCT05882045↗

    PeptideScanner retained ClinicalTrials.gov record NCT05882045 at 2026-08-10T18:10:03.944Z. Its registry update date was 2026-07-30, and PeptideScanner's reviewed identity mapping was retatrutide.↗

  12. Clinical trials

    ClinicalTrials.gov record NCT05929079↗

    PeptideScanner retained ClinicalTrials.gov record NCT05929079 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-30, and PeptideScanner's reviewed identity mapping was retatrutide.↗

  13. Literature metadata

    PubMed record PMID 42527705↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42527705 at 2026-08-10T18:13:57.053Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.↗

  14. Literature metadata

    PubMed record PMID 42493254↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42493254 at 2026-08-10T18:13:56.730Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2026-07-23. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.↗

  15. Clinical trials

    Retatrutide renal-impairment study record updated↗

    ClinicalTrials.gov lists an active, not recruiting Retatrutide study sponsored by Eli Lilly and Company.↗

  16. Literature metadata

    PubMed record PMID 42425580↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42425580 at 2026-08-10T18:13:55.212Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-07-09. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.↗

  17. Literature metadata

    PubMed record PMID 42264536↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42264536 at 2026-07-30T16:14:18.135Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2026-06-09. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.↗

  18. Literature metadata

    PubMed record PMID 41056349↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 41056349 at 2026-07-30T16:20:41.592Z. PubMed recorded a metadata revision date of 2026-05-22 and an Entrez history date of 2025-10-07. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.↗

  19. Regulatory

    FDA warning letter names retatrutide and tirzepatide products↗

    FDA issued a warning letter to Gram Peptides that describes the agency's findings about products marketed with retatrutide and tirzepatide.↗

  20. Literature metadata

    PubMed record PMID 37178114↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 37178114 at 2026-07-30T16:23:33.798Z. PubMed recorded a metadata revision date of 2026-03-27 and an Entrez history date of 2023-05-13. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.↗

  21. Literature metadata

    PubMed record PMID 40735804↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 40735804 at 2026-07-30T16:23:38.757Z. PubMed recorded a metadata revision date of 2026-03-07 and an Entrez history date of 2025-07-30. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.↗

  22. Literature metadata

    PubMed record PMID 39868848↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 39868848 at 2026-07-30T16:31:18.163Z. PubMed recorded a metadata revision date of 2026-01-27 and an Entrez history date of 2025-01-27. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.↗

Source year

2025

4 records
  1. Literature metadata

    Retatrutide.↗

    PubMed lists PMID 39429457 in Clinical diabetes : a publication of the American Diabetes Association as Journal Article, with publication-date metadata of 2024-08-01 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Triple-Hormone-Receptor Agonist Retatrutide for Obesity.↗

    PubMed lists PMID 37888925 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Triple-Hormone-Receptor Agonist Retatrutide for Obesity.↗

    PubMed lists PMID 37888926 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply.↗

    PubMed lists PMID 37888927 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2024

1 record
  1. Literature metadata

    Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide.↗

    PubMed lists PMID 39019866 in Cell discovery as Letter, with publication-date metadata of 2024-07-17 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗